Nomura Holdings Fiscal Q1 Net Income Increases, Total Revenue Falls-February 2024-www.financetom.com

Nomura Holdings Fiscal Q1 Net Income Increases, Total Revenue Falls

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Nomura Holdings Fiscal Q1 Net Income Increases, Total Revenue Falls

Jul 29, 2025 3:43 AM

06:19 AM EDT, 07/29/2025 (MT Newswires) -- Nomura Holdings ( NMR ) reported fiscal Q1 net income Tuesday of 35.19 Japanese yen ($0.24) per basic share, up from 23.33 yen a year earlier.

A single analyst polled by FactSet expected 37.49 yen.

Total revenue for the quarter ended June 30 was 1.157 trillion yen, compared with 1.218 trillion yen a year earlier.

Analyst estimates were not readily available for comparison.

Previous page： Firm Capital Mortgage Investment Upsizes Debenture Offering to $25 Million Next page： Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Firm Capital Mortgage Investment Upsizes Debenture Offering to $25 Million

Oct 7, 2025

11:03 AM EDT, 10/07/2025 (MT Newswires) -- Firm Capital Mortgage Investment ( FCMGF ) said Tuesday that it has upsized its bought-deal debenture offering by $5 million, to $25 million. Proceeds will be used to pay down debt. The company will issue 5.5% convertible unsecured subordinated debentures due Dec. 31, 2032 at $1,000 each. The underwriters have also been granted...

Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2

Oct 7, 2025

Adicet Bio Inc. ( ACET ) shares fell Tuesday after the biotechnology company priced an $80 million direct offering, even as early safety and efficacy data from its Phase 1 trial of ADI-001 in autoimmune diseases showed encouraging signs. The company priced a registered direct offering of 70 million shares and pre-funded warrants to purchase 10 million shares at $1.00...

Citius Sets Up Access to Lymphir in Southern Europe

Oct 7, 2025

11:04 AM EDT, 10/07/2025 (MT Newswires) -- Citius Oncology ( CTOR ) said Tuesday it has entered into an exclusive distribution agreement with Greece-based Integris Pharma to make Lymphir available in Southern Europe. The partnership coverage includes Greece, Cyprus, Malta, Bulgaria, and Romania, it said. Lymphir is a targeted immune therapy for relapsed or refractory cutaneous T-cell lymphoma. The deal...

Great Elm Capital Flags $16.5 Million Direct Net Asset Value Hit From First Brands' Bankruptcy

Oct 7, 2025

11:04 AM EDT, 10/07/2025 (MT Newswires) -- Great Elm Capital ( GECC ) said Tuesday that it expects a direct net asset value impact of about $16.5 million for the quarter ended Sept. 30 from its investments in First Brands Group, which filed for bankruptcy in September. On a preliminary basis, Great Elm Capital ( GECC ) estimates its investments...